ISSC vs. RIGL
ISSC (Innovative Solutions and Support, Inc.) and RIGL (Rigel Pharmaceuticals, Inc.) are both stocks. ISSC operates in Aerospace & Defense (Industrials), while RIGL operates in Biotechnology (Healthcare). Over the past 10 years, ISSC returned 21.80%/yr vs 3.28%/yr for RIGL. At a 0.13 correlation, their price movements are largely independent.
Performance
ISSC vs. RIGL - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, ISSC achieves a -2.43% return, which is significantly higher than RIGL's -23.30% return. Over the past 10 years, ISSC has outperformed RIGL with an annualized return of 21.80%, while RIGL has yielded a comparatively lower 3.28% annualized return.
ISSC
- 1D
- -4.59%
- 1M
- -10.25%
- YTD
- -2.43%
- 6M
- 65.59%
- 1Y
- 50.12%
- 3Y*
- 38.47%
- 5Y*
- 24.62%
- 10Y*
- 21.80%
RIGL
- 1D
- 2.40%
- 1M
- 2.24%
- YTD
- -23.30%
- 6M
- -19.45%
- 1Y
- 54.23%
- 3Y*
- 27.10%
- 5Y*
- -3.96%
- 10Y*
- 3.28%
ISSC vs. RIGL - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
ISSC Innovative Solutions and Support, Inc. | -2.43% | 121.78% | 0.12% | 3.77% | 25.32% | 0.61% | 29.83% | 158.41% | -23.13% | -11.71% |
RIGL Rigel Pharmaceuticals, Inc. | -23.30% | 154.64% | 16.00% | -3.33% | -43.40% | -24.29% | 63.55% | -6.96% | -40.72% | 63.03% |
Correlation
The correlation between ISSC and RIGL is 0.23, which is low. Their price movements are largely independent, making them effective diversification partners.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.23 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.12 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.12 |
Correlation (10Y) Calculated over the trailing 10-year period | 0.11 |
Correlation (All Time) Calculated using the full available price history since Nov 29, 2000 | 0.13 |
The correlation between ISSC and RIGL shifts across timeframes, from 0.11 (10 years) to 0.23 (1 year), reflecting how their relationship changes across market environments.
Fundamentals
ISSC:
$338.23M
RIGL:
$646.69M
ISSC:
$0.94
RIGL:
$19.21
ISSC:
19.62
RIGL:
1.71
ISSC:
0.50
RIGL:
0.00
ISSC:
3.69
RIGL:
2.08
ISSC:
4.69
RIGL:
1.62
ISSC:
$90.56M
RIGL:
$299.77M
ISSC:
$44.22M
RIGL:
$279.95M
ISSC:
$26.70M
RIGL:
$125.80M
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
ISSC vs. RIGL — Risk / Return Rank
ISSC
RIGL
ISSC vs. RIGL - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Innovative Solutions and Support, Inc. (ISSC) and Rigel Pharmaceuticals, Inc. (RIGL). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| ISSC | RIGL | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -0.17 | ||
| Sortino ratioReturn per unit of downside risk | -0.27 | ||
| Omega ratioGain probability vs. loss probability | 1.18 | 1.20 | -0.02 |
| Calmar ratioReturn relative to maximum drawdown | 0.87 | 1.09 | -0.22 |
| Martin ratioReturn relative to average drawdown | 1.59 | 1.91 | -0.32 |
Loading charts...
Drawdowns
ISSC vs. RIGL - Drawdown Comparison
The maximum ISSC drawdown since its inception was -89.03%, smaller than the maximum RIGL drawdown of -99.37%. Use the drawdown chart below to compare losses from any high point for ISSC and RIGL.
Loading charts...
Drawdown Indicators
| ISSC | RIGL | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -89.03% | -99.37% | +10.34% |
Max Drawdown (1Y)Largest decline over 1 year | -57.83% | -50.08% | -7.75% |
Max Drawdown (3Y)Largest decline over 3 years | -57.83% | -57.75% | -0.08% |
Max Drawdown (5Y)Largest decline over 5 years | -57.83% | -85.24% | +27.41% |
Max Drawdown (10Y)Largest decline over 10 years | -62.41% | -86.40% | +23.99% |
Current DrawdownCurrent decline from peak | -39.53% | -96.93% | +57.40% |
Average DrawdownAverage peak-to-trough decline | -50.58% | -90.91% | +40.33% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 31.63% | 28.64% | +2.99% |
Volatility
ISSC vs. RIGL - Volatility Comparison
Innovative Solutions and Support, Inc. (ISSC) has a higher volatility of 25.92% compared to Rigel Pharmaceuticals, Inc. (RIGL) at 12.05%. This indicates that ISSC's price experiences larger fluctuations and is considered to be riskier than RIGL based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| ISSC | RIGL | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 25.92% | 12.05% | +13.87% |
Volatility (6M)Calculated over the trailing 6-month period | 65.82% | 36.64% | +29.18% |
Volatility (1Y)Calculated over the trailing 1-year period | 83.28% | 69.89% | +13.39% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 59.11% | 85.46% | -26.35% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 57.12% | 82.81% | -25.69% |
Dividends
ISSC vs. RIGL - Dividend Comparison
Neither ISSC nor RIGL has paid dividends to shareholders.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
ISSC Innovative Solutions and Support, Inc. | 0.00% | 0.00% | 0.00% | 0.00% | 0.01% | 0.00% | 17.64% |
RIGL Rigel Pharmaceuticals, Inc. | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Financials
ISSC vs. RIGL - Financials Comparison
This section allows you to compare key financial metrics between Innovative Solutions and Support, Inc. and Rigel Pharmaceuticals, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
ISSC vs. RIGL - Profitability Comparison
ISSC - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Innovative Solutions and Support, Inc. reported a gross profit of 11.43M and revenue of 22.37M. Therefore, the gross margin over that period was 51.1%.
RIGL - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Rigel Pharmaceuticals, Inc. reported a gross profit of 54.21M and revenue of 58.82M. Therefore, the gross margin over that period was 92.2%.
ISSC - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Innovative Solutions and Support, Inc. reported an operating income of 4.94M and revenue of 22.37M, resulting in an operating margin of 22.1%.
RIGL - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Rigel Pharmaceuticals, Inc. reported an operating income of 11.89M and revenue of 58.82M, resulting in an operating margin of 20.2%.
ISSC - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Innovative Solutions and Support, Inc. reported a net income of 3.43M and revenue of 22.37M, resulting in a net margin of 15.4%.
RIGL - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Rigel Pharmaceuticals, Inc. reported a net income of 8.65M and revenue of 58.82M, resulting in a net margin of 14.7%.
Frequently Asked Questions
ISSC and RIGL have a correlation of 0.23, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
ISSC has higher volatility (25.92%) compared to RIGL (12.05%). In terms of maximum drawdown, ISSC dropped -89.03% vs RIGL's -99.37%.
RIGL currently has the higher Sharpe Ratio (0.78 vs 0.60), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for ISSC and RIGL
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer